On 28 November 2025, Billev Pharma East Ltd. participated in the European Pharmacovigilance Congress 2025 in Milan, one of the key international events in the field of pharmacovigilance and drug safety. The congress, organised by Pharma Education Center, brought together experts, regulatory authorities, and industry professionals to discuss the latest developments, challenges, and opportunities in pharmacovigilance and safety monitoring across Europe and beyond.
Representing Billev Pharma East at the event were Martina Prevolšek and Elena Radchenko, who joined leading professionals to exchange insights on evolving regulatory expectations, risk management strategies, and advances in post-marketing safety. Their participation underlines Billev Pharma East’s dedication to staying connected with the wider pharmacovigilance community and contributing to discussions that shape best practices in the industry.
Billev Pharma East combines deep pharmacovigilance expertise with comprehensive regulatory support services, helping pharmaceutical and biotech companies meet evolving PV requirements and advance patient safety. The company’s service offerings include adverse drug reaction report handling and reporting, signal detection and evaluation, support for pharmacovigilance outsourcing, development and implementation of a tailored pharmacovigilance risk management plan, and structured pharmacovigilance audit services. In addition, Billev Pharma East provides Qualified Person for Pharmacovigilance (QPPV) support, Individual Case Safety Report (ICSR) management, pharmacovigilance system setup and maintenance, and strategic regulatory and compliance guidance. By integrating robust safety processes with strong regulatory affairs and quality management capabilities, Billev Pharma East supports clients in navigating complex pharmacovigilance requirements across markets.
Highlights from the conference in Milan
The European Pharmacovigilance Congress 2025 in Milan featured a hybrid format, with virtual sessions on earlier dates and an in-person day in Milan on 28 November, hosting workshops and networking opportunities. The conference programme covered core topics such as modern signal detection methodologies, benefit-risk evaluation, regulatory perspectives, and the role of real-world data in safety monitoring.
Participants at the event benefited from a rich agenda of scientific content, interactive discussions, and the chance to connect with peers from the pharmaceutical industry, regulatory bodies, and consulting organisations. These interactions were invaluable for gaining up-to-date insights, benchmarking practices, and strengthening professional networks in pharmacovigilance.
Looking ahead to 2026
Building on the momentum from the European Pharmacovigilance Congress 2025 in Milan, Billev Pharma East is pleased to confirm its continued active participation in international pharmacovigilance events in 2026. From 18–19 May 2026, the Pharmacovigilance and Drug Safety Conference will take place in London, United Kingdom — a major global forum where professionals gather to advance discussions on safety, regulatory innovation, and future trends.
We are especially proud to share that Jana Brajdih Čendak will be joining the conference as a featured speaker, representing Billev Pharma East and contributing her expertise to the international conversation on pharmacovigilance and drug safety. Her participation highlights the company’s ongoing commitment to thought leadership and professional excellence within the field.
More information about the 2026 London conference will be available on the official event website as details are published.
Image credits:
Hero image: Photo by Ouael Ben Salah by Unsplash